Home
Our Mission
The Solution
Clinical Trials
Media
Clinical Development
Our Team
Contact Us
Menu
Home
Our Mission
The Solution
Clinical Trials
Media
Clinical Development
Our Team
Contact Us
Long-Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer’s Disease Dementia, Phase I
Prev
Previous
Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes
Next
Johns Hopkins: Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration
Next
Facebook-f
Twitter
Linkedin-in
Instagram
Youtube
Copyright © 2023 Kurve Therapeutics
Home
Our Mission
The Solution
Clinical Trials
Media
Clinical Development
Our Team
Contact Us
Home
Our Mission
The Solution
Clinical Trials
Media
Clinical Development
Our Team
Contact Us